{"transactions":[{"id":1698088,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T16:07:35.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":44577,"derivative":{"exercise_price":0.37,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-23-073837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000095017023073837/ownership.xml","form_type":"4"}},{"id":1698087,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-29T16:07:35.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0.37,"value":9250.0,"ownership":{"direct":true},"balance_after":276108,"source":{"system":"sec-edgar","filing":"0000950170-23-073837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000095017023073837/ownership.xml","form_type":"4"}},{"id":1829707,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-14T16:20:33.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of the date of this filing, 67,156 shares subject to the option are vested and exercisable. 2,421 shares subject to such option vest and become exercisable in substantially equal monthly installments until August 13, 2023."}],"balance_after":69577,"derivative":{"exercise_price":0.37,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-033003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000095017023033003/ownership.xml","form_type":"4"}},{"id":1829706,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-07-14T16:20:33.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0.37,"value":7400.0,"ownership":{"direct":true},"balance_after":251108,"source":{"system":"sec-edgar","filing":"0000950170-23-033003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000095017023033003/ownership.xml","form_type":"4"}},{"id":1879974,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-24T16:38:47.000Z","date":"2023-05-22","kind":"gift","planned":false,"acquired":false,"shares":1580,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":231108,"source":{"system":"sec-edgar","filing":"0000950170-23-023942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000095017023023942/ownership.xml","form_type":"4"}},{"id":1944816,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-20T20:27:49.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":82500,"derivative":{"exercise_price":32.08,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0000899243-23-009180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924323009180/doc4.xml","form_type":"4"}},{"id":1944815,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-20T20:27:49.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a \"RSU\"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":232688,"source":{"system":"sec-edgar","filing":"0000899243-23-009180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924323009180/doc4.xml","form_type":"4"}},{"id":2057669,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-10T19:19:15.000Z","date":"2023-01-06","kind":"sale","acquired":true,"shares":743,"price":36.7888,"value":27334.0784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.59 to $37.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":214355,"source":{"system":"sec-edgar","filing":"0000899243-23-001520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924323001520/doc4.xml","form_type":"4"}},{"id":2057668,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-10T19:19:15.000Z","date":"2023-01-06","kind":"sale","acquired":true,"shares":1660,"price":36.0789,"value":59890.974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.59 to $36.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":215098,"source":{"system":"sec-edgar","filing":"0000899243-23-001520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924323001520/doc4.xml","form_type":"4"}},{"id":2439019,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-10T20:30:59.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option shall vest and become exercisable on the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":127500,"derivative":{"exercise_price":19,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0000899243-22-001516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924322001516/doc4.xml","form_type":"4"}},{"id":2439018,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T20:30:59.000Z","date":"2022-01-06","kind":"purchase","acquired":true,"shares":6842,"price":19,"value":129998.0,"ownership":{"direct":true},"balance_after":216758,"source":{"system":"sec-edgar","filing":"0000899243-22-001516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924322001516/doc4.xml","form_type":"4"}},{"id":2439017,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":95751,"kind":"person","name":"Olinger Margaret","position":1,"cik":"0001898725","reported_name":"Olinger Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T20:30:59.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":28333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a \"RSU\"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first anniversary of the date of the grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":209916,"source":{"system":"sec-edgar","filing":"0000899243-22-001516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898725/000089924322001516/doc4.xml","form_type":"4"}}]}